Shock patients with restrictive cardiomyopathy due to cardiac amyloidosis are refractory to medical treatment. Here, we report a case of early initiation of intra-aortic balloon pumping (IABP) in a patient with cardiac amyloidosis who developed postoperative shock. Continuous hemodiafiltration was also applied to control circulating fluid volume. The mechanical treatments allowed reduction of the doses of catecholamine and diuretics and resulted in full recovery. It is reasonable to initiate IABP and hemofiltration dialysis during the early stages for the appropriate control of hemodynamics and fluid in shock patients with cardiac amyloidosis.
Introduction
Cardiac amyloidosis is a progressive infiltrative cardiomyopathy characterized by restrictive cardiomyopathy and presentation with conduction system diseases (1) . Patients with cardiac amyloidosis due to the senile form of amyloidosis have few causal treatment options. Cardiac amyloidosis is often refractory to conventional medical treatment and is associated with a high mortality rate. Moreover, chronic kidney diseases often co-exist with cardiac amyloidosis, which makes the control of circulating fluid volume difficult (2) .
Intra-aortic balloon pumping (IABP) is used in the treatment of patients with heart failure and cardiogenic shock unresponsive to standard medical management. IABP improves ventricular systolic function; however, it remains unclear whether it also improves left ventricular diastolic function. Here, we report a case of senile cardiac amyloidosis complicated with transient shock state after invasive laparoscopic surgery. However, the patient recovered after early initiation of multidisciplinary mechanical support.
Case Report
A 70-year-old man with a history of frequent admission to the hospital for the treatment of congestive heart failure, was referred to our hospital for further management. Electrocardiography revealed sinus rhythm (heart rate: 75 beats/ min) with left axis deviation, first-degree AV block, and complete left bundle branch block (Fig. 1A) . Chest radiography showed cardiac enlargement (cardio-thoracic ratio: 60%, Fig. 1B ). Transthoracic echocardiography revealed systolic and diastolic dysfunction [ejection fraction (EF): 44%, the ratio of early to late diastolic filling (E/A): 1.5, deceleration time (Dct): 179 msec, E/e': 15], and severe left ventricular hypertrophy with granular sparkling sign (Fig. 1C) . Tc99m pyrophosphate scintigraphy showed pyrophosphate accumulation in cardiac muscles (Fig. 1D ). The precise diagnosis of cardiac amyloidosis requires endomyocardial biopsy. However, this procedure is relatively invasive and cannot be performed routinely. Therefore, subcutaneous tissue biopsy was performed to confirm the presence and type of amyloid deposits. Abdominal wall subcutaneous tissue biopsy showed (Fig. 1E) . Genetic testing for mutant TTR was negative. Accordingly, he was diagnosed as cardiac amyloidosis with senile systemic amyloidosis. During cardiac evaluation, a kidney tumor was identified incidentally on abdominal echography and MRI. Therefore, a laparoscopic kidney excision was scheduled after stabilization of the heart failure. Laparoscopy was performed under general anesthesia. The duration of operation was 3 hours 45 minutes, and amount of bleeding was 170 mL. He did not receive blood transfusion. After operation, the patient was transferred to the general ward without continuous catecholamine infusion, however, he passed into shock several hours later. He did not respond to a large volume of continuous catecholamine infusion, and was thus transferred to the intensive care unit (ICU).
On admission to the ICU, the patient was fully alert and oriented. Clinical examination showed blood pressure of 60/ 40 mmHg with an irregular heart rate of 48 beats/min. He was maintained on oxygen at 3 liters/min. Chest radiography showed further cardiac enlargement and mild pulmonary congestion. Electrocardiography identified atrial fibrillation with severe ventricular conduction disturbance. Laboratory tests showed leukocytosis, high CRP and BNP, and severe renal dysfunction (Table 1) . Transthoracic echocardiography showed restrictive heart failure as revealed by reduction in EF, increase in E/A ratio and E/e', and shortening in Dct, respectively (Table 1) . Right heart catheter data indicated systemic inflammatory response syndrome as revealed by low pulmonary artery pressure (22/11/14 mmHg), low right atrial pressure (2 mmHg), high cardiac output (5.4 L/min), and low systemic vascular resistance (962 dyne*sec*cm -5 ). Based on these results, the shock was considered to be due to systemic inflammatory response syndrome, restrictive heart failure, hypovolemia and paroxysmal atrial fibrillation. The patient underwent cardioversion immediately after transfer to ICU. Despite the large volume of catecholamine infusion, the systolic blood pressure did not increase above 60 mmHg. Therefore, we immediately decided to use IABP for circulation support. Based on the right heart hemodynamic data, we infused a large volume of saline solution. However, it was difficult to control fluid volume by diuretics due to the pre-existing severe renal dysfunction and left nephrectomy. Therefore, we started continuous hemodiafiltration (CHDF) for the proper control of circulating fluid volume. The use of IABP and CHDF allowed for the reduction of the dose of catecholamine and diuretics infusion.
The hemodynamic parameters improved by these multidisciplinary mechanical treatments without causing acute heart failure. The circulatory dynamics remained stable, allowing the withdrawal of IABP after 5 days, and CHDF after 9 days (Fig. 2) . The hemodynamic state remained stable after weaning from mechanical therapy. The pre-discharge or laboratory tests and transthoracic echocardiography showed improvement in BNP, EF, E/A, E/e' and Dct (Table 1) . He was discharged on foot 31 days after admission.
Discussion
We report a patient with restrictive cardiomyopathy associated with senile cardiac amyloidosis who passed into a transient shock after invasive laparoscopic surgery. However, recovery was possible with multidisciplinary mechanical support. Large volumes of catecholamine and diuretic infusion are necessary for the treatment of patients with restrictive cardiomyopathy complicated with shock. However, these patients are often refractory to medical treatment, especially those with renal involvement. In addition, continuous intravenous catecholamine is associated with increased risk of death in patients with advanced heart failure (3). Our patient escaped the vicious cycle following early initiation of IABP and CHDF.
IABP is used in the treatment of patients with cardiogenic shock unresponsive to medical treatment based on the concept of systolic unloading and diastolic augmentation (4) . The systolic unloading improves cardiac function irrespective of the type of heart failure. In contrast, it is believed that diastolic augmentation is less effective in patients with non-ischemic heart failure. Previous studies have reported amyloid deposition in coronary blood vessels and cardiomyocytes in patients with systemic amyloidosis (5) . Cardiac troponin is a marker of heart dysfunction in patients with cardiac amyloidosis because it represents small vessel ischemia, a complication of amyloid deposition in the vessel wall (6) . These results suggest that cardiac amyloidosis causes microvessel ischemia. Furthermore, it is reported that IABP increases peak transmitral E-wave velocity by increasing peak coronary artery flow velocity and left ventricular free-wall early diastolic lengthening velocity, suggesting improvement of left ventricular diastolic function (7). Therefore, the use of IABP for restrictive heart failure with cardiac amyloidosis is a reasonable and effective strategy, similar to use in ischemic heart failure.
It is difficult to control circulating volume appropriately in patients with restrictive heart failure including cardiac amyloidosis, since the use of diuretics in combination with fluid restriction often leads to systemic hypotension. In addition, amyloid patients with renal involvement and severe heart failure develop resistance to diuretics. It was reported recently that CHDF can control fluid volume in volumeoverloaded heart failure and cardiogenic shock without changing the hemodynamic state (8) . Thus, CHDF therapy is safe and effective in hemodynamically unstable patients. In the present patient, systemic inflammatory response syndrome was suspected based on the right heart catheter data.
Severe inflammatory response injures cells, tissues, and organs, and thus such patients should benefit from a reduction in inflammatory cytokines (9) . CHDF can eliminate proinflammatory cytokines, and such elimination may be effective in decompensated heart failure (10). Accordingly, early initiation of CHDF was effective in the treatment of a shock patient with restrictive heart failure complicated with SIRS.
Conclusion
Shock patients with restrictive cardiomyopathy due to cardiac amyloidosis are refractory to medical treatment. It is reasonable to initiate IABP and hemofiltration dialysis during the early stages for the appropriate control of hemodynamics and fluid.
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